House Democrats Push Pharmaceutical Companies To Explain High Costs Of MS Drugs

Two Democratic lawmakers, Rep. Elijah Cummings of Maryland and Rep. Peter Welch of Vermont, are pressing Bayer, Biogen, EMD Serono, Novartis, Sanofi, Teva, and Roche Pharmaceuticals for an explanation of the pricing strategies and whether companies were increasing prices as part of a coordinated effort.

Reuters: U.S. House Democrats Launch Probe Into MS Drug Pricing

U.S. House Democrats said on Thursday they were launching an investigation into why prices for Multiple Sclerosis (MS) treatments have nearly quintupled since 2004, and they sent letters requesting information from seven drugmakers. (Erman, 8/17)

Stat: Lawmakers Push Drug Makers To Explain Soaring Prices For MS Drugs

Two Democratic lawmakers are pressing major pharmaceutical companies to explain their pricing strategies for multiple sclerosis drugs. Reps. Elijah Cummings of Maryland and Peter Welch of Vermont wrote to Bayer, Biogen, EMD Serono, Novartis, Sanofi, Teva, and Roche Pharmaceuticals to request documents that reference pricing strategies. They also asked for information about corporate profits, expenses, patient assistance programs, and drug distribution systems. (Mershon, 8/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics